BG106162A - Трициклени аналгетици - Google Patents

Трициклени аналгетици Download PDF

Info

Publication number
BG106162A
BG106162A BG106162A BG10616201A BG106162A BG 106162 A BG106162 A BG 106162A BG 106162 A BG106162 A BG 106162A BG 10616201 A BG10616201 A BG 10616201A BG 106162 A BG106162 A BG 106162A
Authority
BG
Bulgaria
Prior art keywords
piperidine
dihydro
oxospiro
naphthalene
methoxy
Prior art date
Application number
BG106162A
Other languages
Bulgarian (bg)
English (en)
Inventor
Alain Calvet
Henri Jacobelli
Jocelyne Puaud
Francois Roman
Jacques Hamon
Agnes Grouhel
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of BG106162A publication Critical patent/BG106162A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
BG106162A 1999-06-07 2001-11-30 Трициклени аналгетици BG106162A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13786899P 1999-06-07 1999-06-07
PCT/EP2000/005783 WO2000075116A2 (en) 1999-06-07 2000-06-07 Tricyclic analgesics

Publications (1)

Publication Number Publication Date
BG106162A true BG106162A (bg) 2002-05-31

Family

ID=22479397

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106162A BG106162A (bg) 1999-06-07 2001-11-30 Трициклени аналгетици

Country Status (21)

Country Link
EP (1) EP1235808A2 (zh)
JP (1) JP2003513006A (zh)
KR (1) KR20020010923A (zh)
CN (1) CN1635998A (zh)
AP (1) AP2001002356A0 (zh)
AU (1) AU6428400A (zh)
BG (1) BG106162A (zh)
BR (1) BR0011427A (zh)
CA (1) CA2376076A1 (zh)
EA (1) EA200101117A1 (zh)
HR (1) HRP20010913A2 (zh)
HU (1) HUP0203317A2 (zh)
IL (1) IL146755A0 (zh)
IS (1) IS6175A (zh)
MA (1) MA26795A1 (zh)
MX (1) MXPA01012694A (zh)
NO (1) NO20015966D0 (zh)
PL (1) PL357340A1 (zh)
SK (1) SK17512001A3 (zh)
TR (1) TR200103531T2 (zh)
WO (1) WO2000075116A2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
FR2915099B1 (fr) * 2007-04-19 2009-06-05 Sanofi Aventis Sa Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
PT2670752E (pt) * 2011-02-02 2016-06-14 Vertex Pharma Piperidinamidas pirrolopirazina-espirocíclicas como moduladores de canais iónicos
CN115872873A (zh) * 2022-12-29 2023-03-31 上海泰坦科技股份有限公司 一种双（2-溴乙基）胺氢溴酸盐的重结晶纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917069D0 (en) * 1989-07-26 1989-09-13 Merck Sharp & Dohme Therapeutic agents
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
DE69412067T2 (de) * 1993-01-28 1999-03-25 Merck & Co Inc Substituierte spiro-azaringen als tachykinine rezeptor antagonisten
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
WO1998025604A1 (en) * 1996-12-13 1998-06-18 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
US6013644A (en) * 1997-12-12 2000-01-11 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity

Also Published As

Publication number Publication date
NO20015966L (no) 2001-12-06
TR200103531T2 (tr) 2002-06-21
PL357340A1 (en) 2004-07-26
WO2000075116A3 (en) 2002-07-04
HUP0203317A2 (hu) 2003-02-28
KR20020010923A (ko) 2002-02-06
MXPA01012694A (es) 2003-10-15
IS6175A (is) 2001-11-23
NO20015966D0 (no) 2001-12-06
MA26795A1 (fr) 2004-12-20
JP2003513006A (ja) 2003-04-08
WO2000075116A2 (en) 2000-12-14
BR0011427A (pt) 2002-03-26
AU6428400A (en) 2000-12-28
AP2001002356A0 (en) 2001-12-31
IL146755A0 (en) 2002-07-25
SK17512001A3 (sk) 2002-11-06
CN1635998A (zh) 2005-07-06
EA200101117A1 (ru) 2002-06-27
CA2376076A1 (en) 2000-12-14
HRP20010913A2 (en) 2003-04-30
EP1235808A2 (en) 2002-09-04

Similar Documents

Publication Publication Date Title
FI96690C (fi) Menetelmä valmistaa terapeuttisesti aktiivista bentsopyridopiperidiini-, piperidylideeni- ja -piperatsiiniyhdistettä
US5302599A (en) Therapeutically useful heterocyclic indole compounds
RU2114848C1 (ru) Фторалкоксибензиламинные производные азотсодержащих гетероциклов, фармацевтическая композиция, способ ингибирования действия вещества р у млекопитающих
CA2111461C (en) 3-aminopiperidine derivatives and related nitrogen containing heterocycles
EP0675886B1 (en) Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
HUT65831A (en) Process for producing substituted 3-amino-quinuclidine derivatives and pharmaceutically acceptable salts
PT862567E (pt) 5-azabiciclo(3.1.0)hexilalquil-2-piperidonas e -glutarimidas como antagonistas do receptor de neurocinina
US5104876A (en) Benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use
EP1490361B1 (en) Polycyclic compounds as potent alpha2-adrenoceptor antagonists
JPH01190680A (ja) インドール誘導体およびその製造方法
EP0463810B1 (en) Heterocyclic compound and psychopharmaceutical composition containing same
JP3803268B2 (ja) アザビシクロアルカン誘導体とその治療的使用
JP2015143255A (ja) 疼痛症候群および他の障害の治療法
US4937249A (en) Imide derivatives and their pharmaceutical use
FI106797B (fi) Menetelmä atsabisyklo [2.2.1] heptan-3-onioksiimien valmistamiseksi
JPH08511513A (ja) 神経変性障害の治療において有用なベンズ（ｂ）アゼピン−２，５−ジオン
WO2003057213A2 (en) Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor
US6313309B1 (en) 4-thionaphthyl—1H—imidazoles which are usefulα22-adrenoceptoR agonists/ antagonists
BG106162A (bg) Трициклени аналгетици
US4612312A (en) Glutarimide antianxiety and antihypertensive agents
JP2000505046A (ja) ドーパミン受容体リガンドとしての新規の融合イソキノリン類
US20040266802A1 (en) Tricyclic analgesics
US5334594A (en) Amphoteric tricyclic compound
JP2004269547A (ja) キノキサリンジオン類の製造方法
JPH02200685A (ja) 新規なインドール誘導体